Sanofi Products

Search for Sanofi brands in the alphabetical list.

Locate a product by brand name, then choose the information you need:

• the PIL - Patient Information Leaflet

• the SmPC - Summary of Product Characteristics

• the RMM - Risk Minimisation Materials

While this information about Sanofi products may be helpful, it is not intended to replace the advice of a doctor or other prescriber or another health professional.

Disclaimer

By clicking on the items in the list below, you will leave sanofi.co.uk. You will go to medicines.org.uk, a website which is not operated by Sanofi.

Sanofi has no control over the content or availability of linked sites or resources and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. The existence of a link between this website and any third-party site or resource in no way implies that Sanofi in any way approves of the content of these sites or resources, or any use to which such content may be put. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

If you are having issues accessing one of our Prescription Only Medicines (POM), excluding Vaccines, please visit our Supply Status Page for help.

Valproate is contraindicated in girls and women of childbearing potential unless the conditions of prevent-the valproate pregnancy prevention programme are fulfilled..

Valproate Annual Risk Acknowledgement Form (ARAF) 

This ARAF should be completed by girls and women of childbearing potential with their specialist. Your specialist should review your treatment and complete this form with you at least once a year to make sure you know and have understood all the risks related to the use of valproate during pregnancy and the need to avoid becoming pregnant while taking valproate